ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1523

Presence Of Peripheral Arthritis Delays Spinal Radiographic Progression In Ankylosing Spondylitis: Observation Study Of Korean Spondyloarthropathy Registry (OSKAR) Over 5 Years

Tae-Jong Kim1, Seunghun Lee2, Kyung-Bin Joo3, Dong-Jin Park4, Yong-Wook Park4, Shin-Seok Lee5 and Tae-Hwan Kim6, 1Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea, 2Department of Radiology, Department of Radiology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 3Department of Radiology, Department of Radiology, Hanynag University Hospital for Rheumatic Diseases, Seoul, South Korea, 4Rheumatology, Chonnam National University Medical School, Gwangju, South Korea, 5Dept of Int Med/Rheumatology, Chonnam National University Medical School, Gwangju, South Korea, 6Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), prognostic factors and radiography

  • Tweet
  • Email
  • Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment: II

Session Type: Abstract Submissions (ACR)

Background/Purpose: The most unique feature in ankylosing spondylitis (AS) is subchondral eburnation and syndesmophytes, possibly leading to ankylosis and spinal fusion. So far a clear relationship between spinal bone formation and peripheral arthritis in patients with AS has not been established. The aim of this study was to determine whether presence of peripheral arthritis can affect the progression of structural damage in patients with AS.

Methods: A total of 915 patients with AS from the Observation Study of Korean spondyloArthropathy Registry (OSKAR) cohort were enrolled for this analysis. We used a two-step approach to explore the relationships between the peripheral arthritis and the progression of spinal structural damage in AS. First, all OSKAR data were analyzed in relation to the history of peripheral arthritis on cross-sectional survey. Second, we analyzed the radiographic spinal progression over 5 years according to the presence or absence of peripheral arthritis. The modified Stoke AS Spinal Score (mSASSS) were examined by two experienced radiologists to validate the results. The collection of the clinical parameters was conducted to investigate the associations between clinical factors and the radiographic progression.

Results: The agreement between the two readers regarding mSASSS was very good: ICC coefficient 0.75 (95% CI 0.61-0.82) and 0.71 (95% CI 0.58-0.82) at each time. On cross-sectional survey, in spite of adjusting for multiple comparisons by Bonferroni correction, the patients with history of peripheral arthritis had fewer mSASSS unit than those without history of peripheral arthritis (19.56±1.06 vs 22.67±0.81, p=0.005). In a analysis over 5 years, the mean progression of mSASSS in patients with peripheral arthritis was 3.26±0.58 units, while that of mSASSS in patients without peripheral arthritis was 4.97±0.44 units (p=0.024).

Conclusion: The patients with the peripheral arthritis had slower radiographic spinal damage progression than those without peripheral arthritis.


Disclosure:

T. J. Kim,
None;

S. Lee,
None;

K. B. Joo,
None;

D. J. Park,
None;

Y. W. Park,
None;

S. S. Lee,
None;

T. H. Kim,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/presence-of-peripheral-arthritis-delays-spinal-radiographic-progression-in-ankylosing-spondylitis-observation-study-of-korean-spondyloarthropathy-registry-oskar-over-5-years/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology